Loading
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$3.25
+$0.03 · +0.93%
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Previous close
$3.25
+$0.03 · +0.93%
After-hours
$3.25
$0.00 · 0.00%
Sep 4, 7:30 PM ET
Regular session · ET · Market data may be delayed.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Day range
Current $3.25
52-week range
Current $3.25
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Hold
Wait — insufficient conviction to act
Valuation
80
Undervalued
Sentiment
52
Mixed
Risk
53
Elevated Risk
Momentum
43
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Day range
Current $3.25
52-week range
Current $3.25
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 41.13M USD | 33.65M USD | 28.52M USD | 27.9M USD | 23.49M USD |
| Cost of goods sold | 15.52M USD | 12.31M USD | 11.81M USD | 12.53M USD | 9.72M USD |
| Gross profit | 25.6M USD | 21.33M USD | 16.71M USD | 15.37M USD | 13.77M USD |
| Research and development | 4.39M USD | 5.26M USD | 5.74M USD | 4.96M USD | 2.47M USD |
| Selling, general, and administrative | 23.38M USD | — | — | — | — |
| Operating expenses | 28.58M USD | 27.78M USD | 26.98M USD | 26.15M USD | 20.8M USD |
| Interest income | 293.4K USD | 444.64K USD | 561.33K USD | 145.59K USD | 13.08K USD |
| Depreciation and amortization | 810.5K USD | 772.89K USD | 870.39K USD | 587.14K USD | 463.13K USD |
| Operating income | −2.97M USD | −6.45M USD | −10.27M USD | −10.78M USD | −7.03M USD |
| Net income | −2.64M USD | −6.07M USD | −13.74M USD | −8.66M USD | −4.56M USD |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$6.00
84.62% upsideAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
